5 completed, 1 withdrawn. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 5, Withdrawn 1 |
Follow PH-797804: new trials by email Literature Review of PH-797804 trials Research Report on PH-797804
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804 PH-797804 - Healthy | Phase 1 | Withdrawn | Pfizer | 2014-03-01 | 2013-12-20 | |
| A Study to Investigate the Effect of PH-797804 on QTc Interval PH-797804, Moxifloxacin, Placebo - Healthy | Phase 1 | Completed | Pfizer | 48 | 2013-04-01 | 2013-08-15 |
| A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804 PH-797804, PH-797804 + erythromycin - Healthy | Phase 1 | Completed | Pfizer | 12 | 2012-06-01 | 2012-08-17 |
| A Study To Investigate The Effect Of Food On The Pharmacokinetics Of PH-797804 PH-797804 - Healthy Volunteers | Phase 1 | Completed | Pfizer | 28 | 2011-12-01 | 2012-02-28 |
| Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers PF-03715455, PH-797804, Placebo for PF-03715455 - Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Completed | Pfizer | 39 | 2011-01-01 | 2012-02-02 |
| PH-797804 LPS Study in Healthy Volunteers PH-797804, Placebo - Healthy | Phase 1 | Completed | Pfizer | 24 | 2006-09-01 | 2014-03-14 |
Pulmonary Disease, Chronic Obstructive (2)
Pfizer (6)
Singapore (2) · United Kingdom (2) · United States (1)